Viatris (VTRS): Buy, Sell, or Hold Post Q4 Earnings? [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation. Is now the time to buy Viatris, or should you be careful about including it in your portfolio? Get the full breakdown from our expert analysts, it's free Why Do We Think Viatris Will Underperform? We're glad investors have benefited from the price increase, but we're cautious about Viatris. Here are three reasons we avoid VTRS and a stock we'd rather own. 1. Long-Term Revenue Growth Disappoints A company's long-term performance is an indicator of its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Regrettably, Viatris's sales grew at a tepid 3.7% compounded annual growth rate over the last five years. This fell short of our benchmark for the healthcare sector. Viatris Quarterly Revenue 2. EPS Trending Down We track the long-term change in earnings per share (EPS) because it highlights
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- UBS and BofA Lift Price Targets on Viatris (VTRS) [Yahoo! Finance]Yahoo! Finance
- Viatris settles lawsuit over use of woman's 'immortal' cells to power drug research [Yahoo! Finance]Yahoo! Finance
- GoodRx to offer up to 85% discount on Viatris drugs [Seeking Alpha]Seeking Alpha
- Viatris (VTRS) Delivers Solid 2025 Growth and Robust Cash Flow at Deep Value [Yahoo! Finance]Yahoo! Finance
- UBS Raises Viatris (VTRS) Price Target as Cost Savings and Growth Outlook Improve [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 2/26/26 - Beat
VTRS
Sec Filings
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- VTRS's page on the SEC website